Cizzle Biotechnology (LON:CIZ) Trading 28.3% Higher – Still a Buy?

Cizzle Biotechnology Holdings Plc (LON:CIZ)’s share price traded up 28.3% during mid-day trading on Tuesday . The stock traded as high as GBX 2.79 and last traded at GBX 2.54. 2,405,493 shares were traded during trading, an increase of 270% from the average session volume of 650,303 shares. The stock had previously closed at GBX 1.98.

Cizzle Biotechnology Trading Up 1.6%

The company has a current ratio of 0.48, a quick ratio of 4.66 and a debt-to-equity ratio of -54.35. The business’s 50-day simple moving average is GBX 1.55 and its two-hundred day simple moving average is GBX 1.57. The company has a market capitalization of £10.07 million, a PE ratio of -7.94 and a beta of 0.38.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.